Software aided approaches to structure-based metabolite identification in drug discovery and development

Area of Science:

• Analytical Chemistry
• Computational Chemistry
• Pharmacology

Background:

• Mass spectrometry (MS) advancements have revolutionized metabolite identification.
• Despite instrumental progress, manual data interpretation of large datasets remains a bottleneck.
• Current cheminformatics tools facilitate but do not fully automate metabolite identification.

Purpose of the Study:

• To review the current state of metabolite identification technologies.
• To highlight the challenges in automated structural assignment of drug metabolites.
• To discuss emerging software-guided approaches for unsupervised metabolite identification.

Main Methods:

• Review of technological advances in mass spectrometry instrumentation.
• Analysis of cheminformatics approaches for metabolite prediction (e.g., Meteor, MetaDrug, MetaSite, StarDrop).
• Evaluation of post-acquisition data analysis techniques like mass defect filtering (MDF).

Main Results:

• Accurate mass high-resolution MS has improved metabolite identification capabilities.
• Cheminformatics and MDF offer partial automation, but expert interpretation is still crucial.
• MassMetaSite provides automated, ranked metabolite structure output by integrating prediction and MS data.

Conclusions:

• Fully automated, unsupervised metabolite identification and structural characterization are still under development.
• Integrated approaches combining prediction and analytical data are key milestones.
• Future workflows aim to be structure-driven and generic, moving beyond sample-specific analyses.